Inspire Medical Systems (INSP) to Release Quarterly Earnings on Tuesday

Inspire Medical Systems (NYSE:INSP) is scheduled to post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect Inspire Medical Systems to post earnings of ($0.63) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.53. The business had revenue of $192.51 million for the quarter, compared to analyst estimates of $186.75 million. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The company’s revenue was up 39.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 EPS. On average, analysts expect Inspire Medical Systems to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inspire Medical Systems Trading Down 0.6 %

NYSE:INSP opened at $249.72 on Monday. Inspire Medical Systems has a twelve month low of $123.27 and a twelve month high of $330.00. The firm’s fifty day simple moving average is $213.36 and its 200 day simple moving average is $189.27. The firm has a market capitalization of $7.57 billion, a price-to-earnings ratio of -337.46 and a beta of 1.35.

Analysts Set New Price Targets

A number of equities analysts have weighed in on INSP shares. Morgan Stanley began coverage on Inspire Medical Systems in a report on Tuesday, March 19th. They issued an “overweight” rating and a $250.00 price target for the company. Truist Financial reaffirmed a “buy” rating and set a $280.00 price target on shares of Inspire Medical Systems in a report on Wednesday, March 20th. Royal Bank of Canada assumed coverage on shares of Inspire Medical Systems in a report on Friday, April 19th. They issued an “outperform” rating and a $285.00 price objective on the stock. Mizuho restated a “buy” rating and set a $250.00 target price on shares of Inspire Medical Systems in a research note on Wednesday, March 27th. Finally, KeyCorp initiated coverage on shares of Inspire Medical Systems in a research note on Tuesday, February 6th. They issued an “overweight” rating and a $278.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $272.20.

Insider Buying and Selling at Inspire Medical Systems

In related news, CEO Timothy P. Herbert sold 40,000 shares of the company’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the completion of the transaction, the chief executive officer now directly owns 63,658 shares in the company, valued at approximately $13,055,619.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Timothy P. Herbert sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the sale, the chief executive officer now directly owns 63,658 shares in the company, valued at $13,055,619.22. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Richard Buchholz sold 15,000 shares of the firm’s stock in a transaction on Wednesday, April 17th. The stock was sold at an average price of $230.03, for a total value of $3,450,450.00. Following the completion of the transaction, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at $6,503,178.13. The disclosure for this sale can be found here. Insiders sold 76,371 shares of company stock worth $15,664,278 over the last ninety days. Company insiders own 4.10% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.